These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 12017394

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cefdinir: an expanded-spectrum oral cephalosporin.
    Guay DR.
    Ann Pharmacother; 2000 Dec; 34(12):1469-77. PubMed ID: 11144705
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ceftibuten: a new expanded-spectrum oral cephalosporin.
    Guay DR.
    Ann Pharmacother; 1997 Sep; 31(9):1022-33. PubMed ID: 9296244
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
    Wiseman LR, Benfield P.
    Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
    [Abstract] [Full Text] [Related]

  • 7. Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
    Barriere SL.
    Ann Pharmacother; 1993 Sep; 27(9):1082-9. PubMed ID: 8219444
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
    Sader HS, Jones RN.
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):29-43. PubMed ID: 17266451
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin.
    Guay DR.
    Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S141-6. PubMed ID: 11144395
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cefditoren, a new aminothiazolyl cephalosporin.
    Balbisi EA.
    Pharmacotherapy; 2002 Oct; 22(10):1278-93. PubMed ID: 12389878
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cefditoren pivoxil.
    Darkes MJ, Plosker GL.
    Drugs; 2002 Oct; 62(2):319-36; discussion 337-8. PubMed ID: 11817976
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
    Gwaltney JM, Savolainen S, Rivas P, Schenk P, Scheld WM, Sydnor A, Keyserling C, Leigh A, Tack KJ.
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1517-20. PubMed ID: 9210677
    [Abstract] [Full Text] [Related]

  • 19. Five-day twice daily cefdinir therapy for acute otitis media: microbiologic and clinical efficacy.
    Block SL, Hedrick JA, Kratzer J, Nemeth MA, Tack KJ.
    Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S153-8. PubMed ID: 11144397
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.